生物分析測試服務市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍:按服務分類;疾病適應症;最終用戶和地理位置
市場調查報告書
商品編碼
1362409

生物分析測試服務市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍:按服務分類;疾病適應症;最終用戶和地理位置

Bioanalytical Testing Services Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services ; Disease Indication ; End User, and Geography

出版日期: | 出版商: The Insight Partners | 英文 202 Pages | 訂單完成後即時交付

價格

全球生物分析測試服務市場預計將從2022年的46.4113億美元增加至2030年的101.0882億美元。預計2022年至2030年該市場將以10.2%的年複合成長率成長。

推動市場成長的關鍵因素是製藥公司研發活動外包的增加以及對生物相似藥和生物製劑分析測試的高需求。然而,開發和驗證生物分析方法的挑戰在一定程度上阻礙了市場的成長。

生物分析測試服務市場的市場機會

藥品及其他醫藥產品的研發、生產及銷售是醫藥工業的主要領域。隨著治療年齡相關疾病和慢性病的藥物需求增加,全球藥品消費量也不斷增加。根據世界衛生組織預測,從2020年到2050年,60歲或以上的老年人口預計將增加一倍,到2050年將達到約21億。老年人口的增加將導致慢性病的發生率激增,例如心血管疾病、癌症、高血壓、骨關節炎和糖尿病。因此,慢性病一直是製藥公司關注的主要領域。

新藥開發是資源、成本和時間密集的過程,後期的臨床階段會導致巨大的成本。根據美國國會預算辦公室(CBO)的資料,發現一種藥物並獲得監管部門批准需要 10 至 15年的時間,成本約為 1 至20 億美元。因此,為了降低藥物研發的損耗率,製藥公司致力於遵循美國FDA和其他主要監管機構制定的良好生產規範(GMP)。多家製藥公司選擇生物分析測試服務來進行藥物開發以及臨床和臨床前階段的檢測驗證。學名藥和品牌藥物化合物大多是小分子。學名藥製造商進行並提交生物分析測試結果,以克服專利到期的問題。因此,隨著製藥業的不斷發展,生物分析檢測服務提供者未來的服務需求可能會持續成長,這將為生物分析檢測服務市場帶來新的成長機會。

阻礙生物分析測試服務市場的因素

發展生物分析方法是一個複雜的過程,需要熟練的專業人員採取靈巧的方法。因此,生物分析方法的開發和驗證面臨一些挑戰。據英國一家從事複雜臨床研究的臨床研究組織 Simbec-Orion 指出,FDA 審查人員概述了與生物分析測試方法相關的分析問題、有缺陷的提取技術、計算問題、報告問題和樣品運輸問題等挑戰。在樣品製備和分析階段可能會出現各種分析問題;其中包括 HPLC 分析管柱的劣化;流動相污染; LCMS 中樣品基質的複雜性所引起的問題; LCMS 其他階段的污染。這些阻礙了生物分析測試的驗證,同時影響了品質標準,限制了生物分析測試服務市場的成長。

生物分析測試服務市場:細分概述

根據服務,生物分析測試服務市場分為藥物動力學、生物標記、免疫原性、病毒學測試、細胞分析等。基於細胞的檢測細分市場在2022年佔據最大的市場佔有率。此外,預計該細分市場從2022年到2030年的年複合成長率最高。基於細胞的檢測通常用於確定藥品的生物活性(效力)或藥物物質並發現作用機制(MOA),以及細胞毒性測試和早期原理驗證研究。在免疫原性研究中,它有助於確定患者體內產生的抗體的藥物中和作用。

根據疾病適應症,生物分析測試服務市場分為心血管、神經系統疾病(CNS)、代謝障礙、腫瘤、性健康、骨骼疾病等。2022年,腫瘤學領域佔據市場最大佔有率。此外,由於止痛、化療和其他療法的腫瘤學進步,預計從2022年到2030年,同一細分市場的需求將以最快的年複合成長率成長。

根據最終用戶,生物分析測試服務市場分為製藥和生物製藥公司、合約研究組織(CRO)、合約開發和製造組織(CDMO)等。2022年,製藥和生物製藥公司細分市場佔據最大的市場。此外,預計2022年至2030年該細分市場的需求將以最快的年複合成長率成長。生物分析測試服務目的是消除從藥品生產開始到最終產品發布所包括的風險。因此,生物分析測試服務在藥物發現和開發中的重要性推動了製藥和生物製藥公司領域的生物分析測試服務市場。

生物分析測試服務市場:地理概況

北美在全球生物分析測試服務市場中佔有最大佔有率,而亞太地區則是成長最快的地區。由於製藥業的不間斷成長、各種疾病發病率的激增對開發新藥的需求不斷增加、政府醫療保健支出的增加以及日益成長的醫療費用,預計北美市場在預測期內將成長。偏向於藥品品質保證的外包活動。亞太地區在全球生物分析測試服務測試市場中年複合成長率最高。未來幾年,該地區的市場預計將在中國、印度和日本等國家大幅成長。由於低成本勞動力市場對外包服務的需求不斷增加,亞太市場預計將成長。因此,該地區生物分析測試服務市場參與者在預測期內具有巨大的成長潛力。

在準備生物分析測試服務市場報告時提到的一些主要一手和二手來源包括世界銀行資料、國家衛生服務體系(NHS)、FDA(食品藥物管理局)、EMA(歐洲藥品管理局)和EPA(環境保護局)。

目錄

第1章 簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第2章 執行摘要

  • 重要見解

第3章 研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第4章 生物分析測試服務市場格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 歐洲PEST分析
    • 亞太地區 PEST 分析
    • 南美洲和中美洲 PEST 分析
    • 中東和非洲 PEST 分析

第5章 生物分析測試服務市場 - 主要產業動態

  • 主要市場促進因素:
    • 藥廠增加研發活動外包
    • 對生物相似藥和生物製劑分析測試的高需求
  • 主要市場限制:
    • 生物分析方法開發與驗證的挑戰
  • 主要市場機會
    • 醫藥產業持續成長
  • 未來的趨勢
    • 針對新興罕見疾病的藥物發現和開發活動不斷增加
  • 影響分析:

第6章 生物分析測試服務市場 - 全球市場分析

  • 生物分析測試服務市場收入,2022 -2030

第7章 全球生物分析測試服務市場 - 收入和2030年預測 - 依服務分類

  • 概述
  • 2022年和2030年生物分析測試服務市場收入佔有率(依服務分類)(%)
  • 藥物動力學
  • 生物標記
  • 免疫原性
  • 病毒學檢測
  • 基於細胞的檢測
  • 其他

第8章 全球生物分析測試服務市場 - 收入和2030年預測 - 按疾病適應症

  • 概述
  • 2022年和2030年按疾病適應症分類的生物分析測試服務市場收入佔有率(%)
  • 心血管
  • 神經系統疾病
  • 自體免疫疾病
  • 呼吸疾病
  • 代謝紊亂
  • 腫瘤學
  • 性健康
  • 骨病
  • 其他

第9章 全球生物分析測試服務市場 - 收入和2030年預測 - 依最終用戶

  • 概述
  • 2022年和2030年生物分析測試服務市場收入佔有率(依最終用戶分類)(%)
  • 製藥和生物製藥公司
  • 合約研究組織(CRO)
  • 合約開發與製造組織(CDMO)
  • 其他

第10章 生物分析測試服務市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第11章 Covid-19 前後的影響

  • Covid-19 前後的影響

第12章 生物分析測試服務市場產業格局

  • 概述
  • 生物分析測試服務市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第13章 公司簡介

  • SGS SA
  • Pharmaron Beijing Co Ltd
  • Element Materials Technology Group Ltd
  • CD BioSciences Inc
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Labcorp Drug Development Inc
  • Syneos Health Inc
  • KCAS Bioanalytical and Biomarker Services LLC
  • ICON Plc
  • Intertek Group Plc

第14章 附錄

  • 關於我們
  • 專業術語
Product Code: TIPRE00007336

The global bioanalytical testing services market is expected to reach US$ 10,108.82 million in 2030 from US$ 4,641.13 million in 2022. The market is estimated to grow with a CAGR of 10.2% from 2022 to 2030.

The key factors driving the market's growth are increasing outsourcing of R&D activities by pharmaceutical companies and the high demand for analytical testing of biosimilars and biologics. However, challenges in developing and validating bioanalytical methods are hampering the market's growth to a certain extent.

Market Opportunities of Bioanalytical Testing Services Market

The research & development, production, and distribution of medicinal drugs and other pharmaceutical products are the major areas of the pharmaceutical industry. Global pharmaceutical consumption is rising with the increasing need for drugs to treat age-related diseases and chronic diseases. According to the WHO, the elderly population aged 60 or above is projected to double from 2020 to 2050, reaching ~2.1 billion by 2050. A rise in the geriatric population would contribute to a surge in incidences of chronic diseases, such as cardiovascular diseases, cancer, hypertension, osteoarthritis, and diabetes mellitus. Thus, chronic diseases have been a major area of focus for pharmaceutical companies.

New drug development is a resource-, cost-, and time-intensive process, where later clinical stages result in significant costs. As per the United States Congressional Budget Office (CBO), it takes over 10-15 years and costs around US$ 1-2 billion to discover a drug and obtain regulatory approval. Therefore, to lower the attrition rate in drug research & development, pharmaceutical companies are focusing on following the good manufacturing practices (GMP) set by the US FDA and other major regulatory organizations. Several pharmaceutical companies are opting for bioanalytical testing services for drug development and validation of assays in both clinical and preclinical stages. Generics and branded drug compounds are mostly small molecules. Generics manufacturers conduct and submit bioanalytical testing results to overcome the issue of patent expiration. Thus, with the uninterrupted proliferation of the pharmaceutical industry, bioanalytical testing service providers are likely to experience a continuous rise in demand for their services in the future, which would lead to new growth opportunities in the bioanalytical testing services market.

Factors Hampering Bioanalytical Testing Services Market

Developing bioanalytical methods is a complex process that necessitates a dexterous approach by skilled professionals. As a result, several challenges are associated with the development and validation of biological analysis methods. According to Simbec-Orion, a UK-based clinical research organization for complex clinical studies, FDA reviewers have outlined challenges such as analytical issues, flawed extraction techniques, calculation problems, reporting issues, and sample shipping issues related to bioanalytical testing methods. Various analytical issues may arise during the sample preparation and analysis stage; these include deterioration of analytical columns in HPLC; contamination in the mobile phase; issues arising from the complexity of sample matrices in LCMS; and contamination of other stages of LCMS. These hamper the bioanalytical test validation and simultaneously affect the quality standards, thereby limiting the growth of the bioanalytical testing services market.

Bioanalytical Testing Services Market: Segmental Overview

Based on services, the bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022. Furthermore, the same segment is anticipated to register the highest CAGR from 2022 to 2030. Cell-based assays are commonly used to determine the biological activity (potency) of the drug product or drug substance and discover the mechanism of action (MOA), as well as for cytotoxicity testing and early-stage proof-of-principal studies. While in immunogenicity studies, it helps in determining drug neutralization effect of antibodies produced in the patient's body.

Based on disease indication, the bioanalytical testing services market is segmented into cardiovascular, neurological disorders (CNS), metabolic disorders, oncology, sexual health, bone disease, and others. In 2022, the oncology segment held the market's largest share. Also, the same segment is expected to grow in demand at the fastest CAGR from 2022 to 2030, owing to the advances in oncology for pain relief, chemotherapy, and other therapies.

Based on end users, the bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations (CRO), contract development and manufacturing organization (CDMO), and others. In 2022, the pharmaceutical and biopharmaceutical companies segment held the largest market share. Furthermore, the same segment is expected to witness growth in demand at the fastest CAGR from 2022 to 2030. The bioanalytical test services aim to eliminate the risks involved from the beginning of the pharmaceutical production to the final product release. Thus, the cruciality of bioanalytical testing services in drug discovery and development drives the bioanalytical testing services market for the pharmaceutical and biopharmaceutical companies segment.

Bioanalytical Testing Services Market: Geographical Overview

North America holds the largest share of the global bioanalytical testing services market, whereas the Asia Pacific is the fastest-growing region. The market in North America is expected to grow during the forecast period owing to the uninterrupted growth of the pharmaceuticals industry, the increasing need for developing novel drugs due to an upsurge in the incidences of various diseases, rising healthcare expenditure by governments, and a growing preference for outsourcing activities for the quality assurance of pharmaceutical products. Asia Pacific registered the highest CAGR in the global bioanalytical testing services testing market. The market in the region is expected to grow significantly in countries, including China, India, and Japan, in the coming years. The Asia Pacific market is expected to grow due to the increasing demand for outsourcing services in the low-cost labor markets. Therefore, the region holds huge potential for the bioanalytical testing services market players to grow during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the bioanalytical testing services market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and EPA (Environmental Protection Agency).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in thebioanalytical testing services market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the globalbioanalytical testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving thebioanalytical testing services market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Bioanalytical Testing Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis

5. Bioanalytical Testing Services Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
    • 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
  • 5.2 Key Market Restraints:
    • 5.2.1 Challenges in Development and Validation of Bioanalytical Methods
  • 5.3 Key Market Opportunities
    • 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
  • 5.4 Future Trends
    • 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
  • 5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - Global Market Analysis

  • 6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. Global Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • 7.3 Pharmacokinetics
    • 7.3.1 Overview
    • 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Biomarkers
    • 7.4.1 Overview
    • 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunogenicity
    • 7.5.1 Overview
    • 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Virology Testing
    • 7.6.1 Overview
    • 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1 In-Vitro Virology Testing
        • 7.6.2.1.1 Overview
        • 7.6.2.1.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.2 In-Vivo Virology Testing
        • 7.6.2.2.1 Overview
        • 7.6.2.2.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Cell-Based Assays
    • 7.7.1 Overview
    • 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

  • 8.1 Overview
  • 8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • 8.3 Cardiovascular
    • 8.3.1 Overview
    • 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Neurological Diseases
    • 8.4.1 Overview
    • 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Autoimmune Disorders
    • 8.5.1 Overview
    • 8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Respiratory Diseases
    • 8.6.1 Overview
    • 8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Metabolic Disorders
    • 8.7.1 Overview
    • 8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Oncology
    • 8.8.1 Overview
    • 8.8.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Sexual Health
    • 8.9.1 Overview
    • 8.9.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Bone Disease
    • 8.10.1 Overview
    • 8.10.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.11 Others
    • 8.11.1 Overview
    • 8.11.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biopharmaceutical Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organization (CRO)
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Contract Development And Manufacturing Organization (CDMO)
    • 9.5.1 Overview
    • 9.5.2 Contract Development And Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. Bioanalytical Testing Services Market - Geographical Analysis

  • 10.1 North America Bioanalytical Testing Services Market, Revenue And Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.1 North America Bioanalytical Testing Services Market, by Services
        • 10.1.2.1.1 North America Bioanalytical Testing Services Market, by Virology Testing
      • 10.1.2.2 North America Bioanalytical Testing Services Market, by Disease Indication
      • 10.1.2.3 North America Bioanalytical Testing Services Market, by End User
      • 10.1.2.4 North America Bioanalytical Testing Services Market, by Country
      • 10.1.2.5 US
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 US Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 US Bioanalytical Testing Services Market, by Services
        • 10.1.2.5.3.1 US Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.2.5.4 US Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.2.5.5 US Bioanalytical Testing Services Market, by End User
      • 10.1.2.6 Canada
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Canada Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Canada Bioanalytical Testing Services Market, by Services
        • 10.1.2.6.3.1 Canada Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.2.6.4 Canada Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.2.6.5 Canada Bioanalytical Testing Services Market, by End User
      • 10.1.2.7 Mexico
        • 10.1.2.7.1 Overview
        • 10.1.2.7.2 Mexico Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.7.3 Mexico Bioanalytical Testing Services Market, by Services
        • 10.1.2.7.3.1 Mexico Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.2.7.4 Mexico Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.2.7.5 Mexico Bioanalytical Testing Services Market, by End User
  • 10.2 Europe Bioanalytical Testing Services Market, Revenue And Forecast to 2030
    • 10.2.1 Overview
    • 10.2.2 Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.2.2.1 Europe Bioanalytical Testing Services Market, by Services
        • 10.2.2.1.1 Europe Bioanalytical Testing Services Market, by Virology Testing
      • 10.2.2.2 Europe Bioanalytical Testing Services Market, by Disease Indication
      • 10.2.2.3 Europe Bioanalytical Testing Services Market, by End User
      • 10.2.2.4 Europe Bioanalytical Testing Services Market by Country
      • 10.2.2.5 Germany
        • 10.2.2.5.1 Overview
        • 10.2.2.5.2 Germany Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.5.3 Germany Bioanalytical Testing Services Market, by Services
        • 10.2.2.5.3.1 Germany Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.5.4 Germany Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.5.5 Germany Bioanalytical Testing Services Market, by End User
      • 10.2.2.6 UK
        • 10.2.2.6.1 Overview
        • 10.2.2.6.2 UK Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.6.3 UK Bioanalytical Testing Services Market, by Services
        • 10.2.2.6.3.1 UK Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.6.4 UK Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.6.5 UK Bioanalytical Testing Services Market, by End User
      • 10.2.2.7 France
        • 10.2.2.7.1 Overview
        • 10.2.2.7.2 France Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.7.3 France Bioanalytical Testing Services Market, by Services
        • 10.2.2.7.3.1 France Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.7.4 France Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.7.5 France Bioanalytical Testing Services Market, by End User
      • 10.2.2.8 Italy
        • 10.2.2.8.1 Overview
        • 10.2.2.8.2 Italy Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.8.3 Italy Bioanalytical Testing Services Market, by Services
        • 10.2.2.8.3.1 Italy Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.8.4 Italy Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.8.5 Italy Bioanalytical Testing Services Market, by End User
      • 10.2.2.9 Spain
        • 10.2.2.9.1 Overview
        • 10.2.2.9.2 Spain Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.9.3 Spain Bioanalytical Testing Services Market, by Services
        • 10.2.2.9.3.1 Spain Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.9.4 Spain Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.9.5 Spain Bioanalytical Testing Services Market, by End User
      • 10.2.2.10 Rest of Europe
        • 10.2.2.10.1 Overview
        • 10.2.2.10.2 Rest of Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.10.3 Rest of Europe Bioanalytical Testing Services Market, by Services
        • 10.2.2.10.3.1 Rest of Europe Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.10.4 Rest of Europe Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.10.5 Rest of Europe Bioanalytical Testing Services Market, by End User
  • 10.3 Asia Pacific Bioanalytical Testing Services Market, Revenue And Forecast to 2030
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.3.2.1 Asia Pacific Bioanalytical Testing Services Market, by Services
        • 10.3.2.1.1 Asia Pacific Bioanalytical Testing Services Market, by Virology Testing
      • 10.3.2.2 Asia Pacific Bioanalytical Testing Services Market, by Disease Indication
      • 10.3.2.3 Asia Pacific Bioanalytical Testing Services Market, by End User
      • 10.3.2.4 Asia Pacific Bioanalytical Testing Services Market by Country
      • 10.3.2.5 China
        • 10.3.2.5.1 Overview
        • 10.3.2.5.2 China Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.5.3 China Bioanalytical Testing Services Market, by Services
        • 10.3.2.5.3.1 China Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.5.4 China Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.5.5 China Bioanalytical Testing Services Market, by End User
      • 10.3.2.6 Japan
        • 10.3.2.6.1 Overview
        • 10.3.2.6.2 Japan Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.6.3 Japan Bioanalytical Testing Services Market, by Services
        • 10.3.2.6.3.1 Japan Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.6.4 Japan Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.6.5 Japan Bioanalytical Testing Services Market, by End User
      • 10.3.2.7 India
        • 10.3.2.7.1 Overview
        • 10.3.2.7.2 India Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.7.3 India Bioanalytical Testing Services Market, by Services
        • 10.3.2.7.3.1 India Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.7.4 India Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.7.5 India Bioanalytical Testing Services Market, by End User
      • 10.3.2.8 Australia
        • 10.3.2.8.1 Overview
        • 10.3.2.8.2 Australia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.8.3 Australia Bioanalytical Testing Services Market, by Services
        • 10.3.2.8.3.1 Australia Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.8.4 Australia Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.8.5 Australia Bioanalytical Testing Services Market, by End User
      • 10.3.2.9 South Korea
        • 10.3.2.9.1 Overview
        • 10.3.2.9.2 South Korea Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.9.3 South Korea Bioanalytical Testing Services Market, by Services
        • 10.3.2.9.3.1 South Korea Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.9.4 South Korea Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.9.5 South Korea Bioanalytical Testing Services Market, by End User
      • 10.3.2.10 Rest of Asia Pacific
        • 10.3.2.10.1 Overview
        • 10.3.2.10.2 Rest of Asia Pacific Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.10.3 Rest of Asia Pacific Bioanalytical Testing Services Market, by Services
        • 10.3.2.10.3.1 Rest of Asia Pacific Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.10.4 Rest of Asia Pacific Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.10.5 Rest of Asia Pacific Bioanalytical Testing Services Market, by End User
  • 10.4 Middle East & Africa Bioanalytical Testing Services Market, Revenue And Forecast to 2030
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.4.2.1 Middle East & Africa Bioanalytical Testing Services Market, by Services
        • 10.4.2.1.1 Middle East & Africa Bioanalytical Testing Services Market, by Virology Testing
      • 10.4.2.2 Middle East & Africa Bioanalytical Testing Services Market, by Disease Indication
      • 10.4.2.3 Middle East & Africa Bioanalytical Testing Services Market, by End User
      • 10.4.2.4 Middle East & Africa Bioanalytical Testing Services Market by Country
      • 10.4.2.5 UAE
        • 10.4.2.5.1 Overview
        • 10.4.2.5.2 UAE Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.5.3 UAE Bioanalytical Testing Services Market, by Services
        • 10.4.2.5.3.1 UAE Bioanalytical Testing Services Market, by Virology Testing
        • 10.4.2.5.4 UAE Bioanalytical Testing Services Market, by Disease Indication
        • 10.4.2.5.5 UAE Bioanalytical Testing Services Market, by End User
      • 10.4.2.6 Saudi Arabia
        • 10.4.2.6.1 Overview
        • 10.4.2.6.2 Saudi Arabia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.6.3 Saudi Arabia Bioanalytical Testing Services Market, by Services
        • 10.4.2.6.3.1 Saudi Arabia Bioanalytical Testing Services Market, by Virology Testing
        • 10.4.2.6.4 Saudi Arabia Bioanalytical Testing Services Market, by Disease Indication
        • 10.4.2.6.5 Saudi Arabia Bioanalytical Testing Services Market, by End User
      • 10.4.2.7 South Africa
        • 10.4.2.7.1 Overview
        • 10.4.2.7.2 South Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.7.3 South Africa Bioanalytical Testing Services Market, by Services
        • 10.4.2.7.3.1 South Africa Bioanalytical Testing Services Market, by Virology Testing
        • 10.4.2.7.4 South Africa Bioanalytical Testing Services Market, by Disease Indication
        • 10.4.2.7.5 South Africa Bioanalytical Testing Services Market, by End User
      • 10.4.2.8 Rest of Middle East & Africa
        • 10.4.2.8.1 Overview
        • 10.4.2.8.2 Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.8.3 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Services
        • 10.4.2.8.3.1 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Virology Testing
        • 10.4.2.8.4 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Disease Indication
        • 10.4.2.8.5 Rest of Middle East & Africa Bioanalytical Testing Services Market, by End User
  • 10.5 South & Central America Bioanalytical Testing Services Market, Revenue And Forecast to 2030
    • 10.5.1 Overview
    • 10.5.2 South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.5.2.1 South & Central America Bioanalytical Testing Services Market, by Services
        • 10.5.2.1.1 South & Central America Bioanalytical Testing Services Market, by Virology Testing
      • 10.5.2.2 South & Central America Bioanalytical Testing Services Market, by Disease Indication
      • 10.5.2.3 South & Central America Bioanalytical Testing Services Market, by End User
      • 10.5.2.4 South & Central America Bioanalytical Testing Services Market by Country
      • 10.5.2.5 Brazil
        • 10.5.2.5.1 Overview
        • 10.5.2.5.2 Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.5.3 Brazil Bioanalytical Testing Services Market, by Services
        • 10.5.2.5.3.1 Brazil Bioanalytical Testing Services Market, by Virology Testing
        • 10.5.2.5.4 Brazil Bioanalytical Testing Services Market, by Disease Indication
        • 10.5.2.5.5 Brazil Bioanalytical Testing Services Market, by End User
      • 10.5.2.6 Argentina
        • 10.5.2.6.1 Overview
        • 10.5.2.6.2 Argentina Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.6.3 Argentina Bioanalytical Testing Services Market, by Services
        • 10.5.2.6.3.1 Argentina Bioanalytical Testing Services Market, by Virology Testing
        • 10.5.2.6.4 Argentina Bioanalytical Testing Services Market, by Disease Indication
        • 10.5.2.6.5 Argentina Bioanalytical Testing Services Market, by End User
      • 10.5.2.7 Rest of South & Central America
        • 10.5.2.7.1 Overview
        • 10.5.2.7.2 Rest of South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.7.3 Rest of South & Central America Bioanalytical Testing Services Market, by Services
        • 10.5.2.7.3.1 Rest of South & Central America Bioanalytical Testing Services Market, by Virology Testing
        • 10.5.2.7.4 Rest of South & Central America Bioanalytical Testing Services Market, by Disease Indication
        • 10.5.2.7.5 Rest of South & Central America Bioanalytical Testing Services Market, by End User

11. Pre & Post Covid-19 Impact

  • 11.1 Pre & Post Covid-19 Impact

12. Bioanalytical Testing Services Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Bioanalytical Testing Services Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 SGS SA
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Pharmaron Beijing Co Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Element Materials Technology Group Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 CD BioSciences Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Charles River Laboratories International Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Eurofins Scientific SE
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Labcorp Drug Development Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Syneos Health Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 KCAS Bioanalytical and Biomarker Services LLC
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ICON Plc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Intertek Group Plc
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Bioanalytical Testing Services Market Segmentation
  • Table 2. North America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 3. North America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 4. North America Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - Disease Indication
  • Table 5. North America Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - End User
  • Table 6. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 7. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 8. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 9. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 10. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 11. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 12. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 13. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 14. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 15. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 16. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 17. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 18. Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 19. Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 20. Europe Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - Disease Indication
  • Table 21. Europe Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - End User
  • Table 22. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 23. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 24. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 25. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 26. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 27. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 28. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 29. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 30. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 31. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 32. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 33. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 34. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 35. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 36. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 37. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 38. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 39. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 40. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 41. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 42. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 43. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 44. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 45. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 46. Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 47. Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 48. Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - Disease Indication
  • Table 49. Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - End User
  • Table 50. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 51. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 52. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 53. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 54. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 55. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 56. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 57. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 58. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 59. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 60. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 61. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 62. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 63. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 64. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 65. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 66. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 67. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 68. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 69. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 70. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 71. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 72. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 73. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 74. Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 75. Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 76. Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - Disease Indication
  • Table 77. Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - End User
  • Table 78. UAE Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 79. UAE Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 80. UAE Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 81. UAE Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 82. Saudi Arabia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 83. Saudi Arabia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 84. Saudi Arabia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 85. Saudi Arabia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 86. South Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 87. South Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 88. South Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 89. South Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 90. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 91. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 92. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 93. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 94. South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 95. South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 96. South & Central America Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - Disease Indication
  • Table 97. South & Central America Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - End User
  • Table 98. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 99. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 100. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 101. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 102. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 103. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 104. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 105. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 106. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 107. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 108. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 109. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 110. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 111. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 112. Glossary of Terms, Bioanalytical Testing Services Market

List Of Figures

  • Figure 1. Bioanalytical Testing Services Market Segmentation, By Geography
  • Figure 2. North America - PEST Analysis
  • Figure 3. Europe - PEST Analysis
  • Figure 4. Asia Pacific - PEST Analysis
  • Figure 5. South & Central America - PEST Analysis
  • Figure 6. Middle East & Africa - PEST Analysis
  • Figure 7. Bioanalytical Testing Services Market - Key Industry Dynamics
  • Figure 8. Impact Analysis of Drivers and Restraints
  • Figure 9. Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 10. Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • Figure 11. Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • Figure 20. Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 30. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Contract Development And Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Bioanalytical Testing Services Market, 2022 ($Mn)
  • Figure 35. North America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 36. North America Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 37. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 39. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 40. Europe Bioanalytical Testing Services Market, By Geography, 2022 ($Mn)
  • Figure 41. Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 42. Europe Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 43. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 45. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 46. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 47. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 48. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 49. Bioanalytical Testing Services Market, By Geography, 2022 ($ Million)
  • Figure 50. Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 51. Asia Pacific Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 52. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 53. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 54. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 55. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 56. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 57. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 58. Bioanalytical Testing Services Market, By Geography, 2022 And 2030 ($ Million)
  • Figure 59. Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 60. Middle East & Africa Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 61. UAE Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 62. Saudi Arabia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 63. South Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 64. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 65. Bioanalytical Testing Services Market, By Geography, 2022 ($Mn)
  • Figure 66. South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 67. South & Central America Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 68. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 69. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 70. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 71. Pre & Post Covid-19 Impact
  • Figure 72. Growth Strategies in the Bioanalytical Testing Services Market